Personalized cancer vaccines vanquish melanoma
Scientific American - 06-Jul-2017Six melanoma patients given an experimental, custom-made, neoantigen vaccine. None of their tumo...
Join the club for FREE to access the whole archive and other member benefits.
Professor of Medicine at Harvard Medical School and Associate Physician of Medical Oncology at Dana-Farber Cancer Institute.
Dr. Wu received her MD from Stanford University School of Medicine in 1994. She completed postgraduate training in internal medicine at Brigham and Women's Hospital, followed by a fellowship in medical oncology and hematology at Dana-Farber/Partners CancerCare. In 2000, she joined Dana-Farber, where she currently leads the Division of Stem Cell Transplantation and Cellular Therapies. Her research interests include the identification of targets of the immune response associated with therapies and dissecting the basis of effective human antitumor responses.
Visit website: https://www.dana-farber.org/find-a-doctor/catherine-j-wu/
See also: Dana-Farber Cancer Institute - Comprehensive cancer treatment and research institution in Boston, Massachusetts
Details last updated 10-Jun-2020
Six melanoma patients given an experimental, custom-made, neoantigen vaccine. None of their tumo...
Researchers have been trying to find ways to ramp up the immune response to tumours. Two new tec...